Glycolysis can be regulated at different steps of the process through feedback regulation. The step that is regulated the most is the third step. This regulation is to ensure that the body is not over-producing pyruvate molecules.

The regulation also allows for the storage of glucose molecules into fatty acids. The enzymes upregulate , downregulate , and feedback regulate the process.

Gluconeogenesis GNG is a metabolic pathway that results in the generation of glucose from certain non- carbohydrate carbon substrates. It is a ubiquitous process, present in plants, animals, fungi, bacteria, and other microorganisms.

It is one of two primary mechanisms — the other being degradation of glycogen glycogenolysis — used by humans and many other animals to maintain blood sugar levels , avoiding low levels hypoglycemia. In humans, substrates for gluconeogenesis may come from any non-carbohydrate sources that can be converted to pyruvate or intermediates of glycolysis see figure.

For the breakdown of proteins , these substrates include glucogenic amino acids although not ketogenic amino acids ; from breakdown of lipids such as triglycerides , they include glycerol , odd-chain fatty acids although not even-chain fatty acids, see below ; and from other parts of metabolism they include lactate from the Cori cycle.

Under conditions of prolonged fasting, acetone derived from ketone bodies can also serve as a substrate, providing a pathway from fatty acids to glucose. The gluconeogenesis pathway is highly endergonic until it is coupled to the hydrolysis of ATP or guanosine triphosphate GTP , effectively making the process exergonic.

For example, the pathway leading from pyruvate to glucosephosphate requires 4 molecules of ATP and 2 molecules of GTP to proceed spontaneously. These ATPs are supplied from fatty acid catabolism via beta oxidation.

Glycogenolysis refers to the breakdown of glycogen. Glucosephosphate can then progress through glycolysis. Glucagon in the liver stimulates glycogenolysis when the blood glucose is lowered, known as hypoglycemia.

Adrenaline stimulates the breakdown of glycogen in the skeletal muscle during exercise. Glycogenesis refers to the process of synthesizing glycogen.

The pentose phosphate pathway is an alternative method of oxidizing glucose. Fructose must undergo certain extra steps in order to enter the glycolysis pathway. Lactose, or milk sugar, consists of one molecule of glucose and one molecule of galactose.

Many steps of carbohydrate metabolism allow the cells to access energy and store it more transiently in ATP. Typically, the complete breakdown of one molecule of glucose by aerobic respiration i.

involving glycolysis, the citric-acid cycle and oxidative phosphorylation , the last providing the most energy is usually about 30—32 molecules of ATP. Hormones released from the pancreas regulate the overall metabolism of glucose. The level of circulatory glucose known informally as "blood sugar" , as well as the detection of nutrients in the Duodenum is the most important factor determining the amount of glucagon or insulin produced.

The release of glucagon is precipitated by low levels of blood glucose, whereas high levels of blood glucose stimulates cells to produce insulin. Because the level of circulatory glucose is largely determined by the intake of dietary carbohydrates, diet controls major aspects of metabolism via insulin.

Regardless of insulin levels, no glucose is released to the blood from internal glycogen stores from muscle cells. Carbohydrates are typically stored as long polymers of glucose molecules with glycosidic bonds for structural support e.

chitin , cellulose or for energy storage e. glycogen , starch. However, the strong affinity of most carbohydrates for water makes storage of large quantities of carbohydrates inefficient due to the large molecular weight of the solvated water-carbohydrate complex.

In most organisms, excess carbohydrates are regularly catabolised to form acetyl-CoA , which is a feed stock for the fatty acid synthesis pathway; fatty acids , triglycerides , and other lipids are commonly used for long-term energy storage.

The hydrophobic character of lipids makes them a much more compact form of energy storage than hydrophilic carbohydrates. Gluconeogenesis permits glucose to be synthesized from various sources, including lipids. In some animals such as termites [20] and some microorganisms such as protists and bacteria , cellulose can be disassembled during digestion and absorbed as glucose.

Contents move to sidebar hide. Article Talk. Read Edit View history. Tools Tools. What links here Related changes Upload file Special pages Permanent link Page information Cite this page Get shortened URL Download QR code Wikidata item. Download as PDF Printable version.

In other projects. Wikimedia Commons. Biochemical process in living organisms. Surgery Oxford. doi : Lehninger principles of biochemistry. Cox, Michael M. New York: W.

Freeman and Company. ISBN OCLC Encyclopedia of Food and Health. Guyton and Hall Textbook of Medical Physiology E-Book 13 ed. Elsevier Health Sciences.

Lehninger Principles of Biochemistry. USA: Worth Publishers. Archived from the original on August 26, Retrieved September 8, In Reese WO ed. Dukes' Physiology of Domestic Animals 12th ed. Cornell Univ. PLOS Computational Biology. Bibcode : PLSCB PMC PMID Journal of Cellular Physiology.

S2CID Harper's illustrated Biochemistry, 30th edition. USA: McGraw Hill. Clinical Biochemistry. Advanced Nutrition and Human Metabolism. Cengage Learning. Archives of Biochemistry and Biophysics.

ISSN Biochemistry Free for All. Oregon State University. Endocrinology: Adult and Pediatric. A review". The Canadian Veterinary Journal. Bibcode : Natur. Journal of General Microbiology. Metabolism , catabolism , anabolism. Metabolic pathway Metabolic network Primary nutritional groups.

Purine metabolism Nucleotide salvage Pyrimidine metabolism Purine nucleotide cycle. Pentose phosphate pathway Fructolysis Polyol pathway Galactolysis Leloir pathway. Glycosylation N-linked O-linked.

Photosynthesis Anoxygenic photosynthesis Chemosynthesis Carbon fixation DeLey-Doudoroff pathway Entner-Doudoroff pathway. Xylose metabolism Radiotrophism. Fatty acid degradation Beta oxidation Fatty acid synthesis. Steroid metabolism Sphingolipid metabolism Eicosanoid metabolism Ketosis Reverse cholesterol transport.

Metal metabolism Iron metabolism Ethanol metabolism Phospagen system ATP-PCr. Metabolism map. Carbon fixation. Knockdown of CRTC2 in mice by RNAi reduced blood glucose levels and led to a concomitant repression of gluconeogenic gene expression.

The forkhead box O FoxOs belongs to a class of forkhead families of transcription, which recognize the AT-rich insulin response element on the promoter. Peroxisome proliferator-activated receptor gamma coactivator 1 alpha PGC-1α , a known coactivator for nuclear receptors, functions as a key transcriptional coactivator for FoxO1 in hepatic gluconeogenesis.

In this case, PRMT1 promotes the asymmetric dimethylation of arginine and in FoxO1, which blocks the binding of Akt and the subsequent Akt-mediated phosphorylation of the adjacent serine residue serine , thus enhancing the nuclear localization of FoxO1.

Nuclear receptors belong to the superfamily of transcription factors that possess two Cys2-His2 type zinc finger motifs as a DNA binding domain as well as both ligand-independent and ligand-dependent transactivation domains.

Nuclear receptors can be classified into one of three subgroups based on their dimer-forming potential. Homodimeric nuclear receptors are also called cytosolic receptors because they reside in the cytosol and associate with molecular chaperones such as heat-shock proteins. On binding to the ligand, they form homodimers and translocate to the nucleus to bind a specific response element termed the hormone response element to elicit the ligand-dependent transcriptional response.

Most of the steroid hormone receptors, such as the glucocorticoid receptor GR , estrogen receptor ER , and progesterone receptor PR , belong to this subfamily. By contrast, heterodimeric nuclear receptors reside in the nucleus and are bound to their cognate binding sites together with the universal binding partner retinoid X receptor RXR.

Examples of this class of nuclear receptors include members of peroxisome proliferator-activated receptors, LXRs, vitamin D receptors and thyroid hormone receptors.

The final subclasses of nuclear receptors are types that function as monomers. They usually lack specific endogenous ligands and are often called orphan nuclear receptors. Some of them also lack DNA binding domain and thus function as transcriptional repressors of various transcription factors, including members of nuclear receptors.

They are called atypical orphan nuclear receptors. Among the homodimeric nuclear receptors, the role of GR has been linked to the control of hepatic gluconeogenesis. GR is activated by cortisol, which is released from the adrenal cortex in response to chronic stresses such as prolonged fasting.

The same response elements were also shown to be recognized and regulated by hepatocyte nuclear factor 4 HNF4 , a member of heterodimeric nuclear receptors, which suggests that these nuclear receptors could coordinately function to control hepatic gluconeogenesis in response to fasting.

In accordance with this idea, the activity of these nuclear receptors can be effectively integrated by the function of transcriptional co-activator PGC-1α. Recently, estrogen-related receptor gamma ERRγ , a member of monomeric nuclear receptors, was shown to be involved in the regulation of hepatic gluconeogenesis.

This factor regulates hepatic gluconeogenesis by binding to unique response elements that are distinct from the known nuclear receptor-binding sites in the promoters of PEPCK and G6Pase. Inhibition of ERRγ activity by injecting either RNAi or the inverse agonist GSK effectively reduced hyperglycemia in diabetic mice, suggesting that the control of this factor might potentially be beneficial in the treatment of patients with metabolic diseases.

As is the case for other nuclear receptors that control hepatic gluconeogenesis, ERRγ activity is further enhanced by interaction with the transcriptional coactivator PGC-1α, showing that this coactivator functions as a master regulator for the hepatic glucose metabolism.

Three members of atypical orphan nuclear receptors, the small heterodimer partner SHP, also known as NR0B2 ; the dosage-sensitive sex reversal, adrenal hypoplasia critical region, on chromosome X DAX-1, also known as NR0B1 ; and the SHP-interacting leucine zipper protein SMILE are implicated in the transcriptional repression of hepatic gluconeogenesis.

Interestingly, metformin directly activates the transcription of SHP via an AMPK-mediated pathway. SHP directly inhibits cAMP-dependent transcription by binding to CREB, resulting in the reduced association of CREB with CRTC2.

These results provide a dual mechanism for a metformin-AMPK dependent pathway to inhibit hepatic gluconeogenesis at the transcriptional level; an acute regulation of CRTC2 phosphorylation to inhibit the CRTC2-CREB-dependent transcriptional circuit; and a longer-term regulation of gluconeogenic transcription by enhanced SHP expression.

Both DAX-1 and SMILE were shown to repress hepatic gluconeogenesis by inhibiting HNF4-dependent transcriptional events. Interestingly, SMILE was shown to directly replace PGC-1α from HNF4 and the gluconeogenic promoters, suggesting that this factor could potentially function as a major transcriptional repressor of hepatic gluconeogenesis in response to insulin signaling.

Further study is necessary to fully understand the relative contribution of these nuclear receptors in the control of glucose homeostasis in both physiological conditions and pathological settings.

In this review, we attempted to describe the current understanding of the regulation of glucose metabolism in the mammalian liver. Under feeding conditions, glucose, a major hexose monomer of dietary carbohydrate, is taken up in the liver and oxidized via glycolysis.

The excess glucose that is not utilized as an immediate fuel for energy is stored initially as glycogen and is later converted into triacylglycerols via lipogenesis.

Glycogenesis is activated via the insulin-Akt-mediated inactivation of GSK-3, leading to the activation of glycogen synthase and the increased glycogen stores in the liver.

Insulin is also critical in the activation of PP1, which functions to dephosphorylate and activate glycogen synthase. Glycolysis is controlled by the regulation of three rate-limiting enzymes: GK, PFK-1 and L-PK. The activities of these enzymes are acutely regulated by allosteric regulators such as ATP, AMP, and F26BP but are also controlled at the transcription level.

Two prominent transcription factors are SREBP-1c and ChREBP, which regulate not only the aforementioned glycolytic enzyme genes but also the genes encoding enzymes for fatty acid biosynthesis and triacylglycerol synthesis collectively termed as lipogenesis.

The importance of these transcription factors in the control of glycolysis and fatty acid biosynthesis has been verified by knockout mouse studies, as described in the main text.

The liver also has a critical role in controlling glucose homeostasis under fasting conditions. Initially, insulin counterregulatory hormones such as glucagon and epinephrine are critical in activating the PKA-driven kinase cascades that promote glycogen phosphorylase and glycogenolysis in the liver, thus enabling this tissue to provide enough fuel for peripheral tissues such as the brain, red blood cells and muscles.

Subsequently, these hormones together with adrenal cortisol are crucial in initiating the transcriptional activation of gluconeogenesis such as PC, PEPCK and G6Pase.

The major transcription factors involved in the pathway include CREB, FoxO1 and members of nuclear receptors, with aid from transcriptional coactivators such as CRTC, PGC-1α and PRMTs.

These adaptive responses are critical for maintaining glucose homeostasis in times of starvation in mammals. Further study is necessary by using liver-specific knockout mice for each regulator of hepatic glucose metabolism to provide better insights into the intricate control mechanisms of glucose homeostasis in mammals.

Nordlie RC, Foster JD, Lange AJ. Regulation of glucose production by the liver. Annul Rev Nutr ; 19 : — Article CAS Google Scholar. Towle HC, Kaytor EN, Shih HM. Regulation of the expression of lipogenic enzyme genes by carbohydrate. Annu Rev Nutr ; 17 : — Article CAS PubMed Google Scholar.

Roach PJ. Glycogen and its metabolism. Curr Mol Med ; 2 : — van de Werve G, Jeanrenaud B. Liver glycogen metabolism: an overview.

Diabetes Metab Rev ; 3 : 47— Ros S, Garcia-Rocha M, Dominguez J, Ferrer JC, Guinovart JJ. Control of liver glycogen synthase activity and intracellular distribution by phosphorylation. The J Biol Chem ; : — Agius L. Role of glycogen phosphorylase in liver glycogen metabolism.

Mol Aspects Med ; 46 : 34— Pilkis SJ, Claus TH. Annu Rev Nutr ; 11 : — Pilkis SJ, Claus TH, el-Maghrabi MR. The role of cyclic AMP in rapid and long-term regulation of gluconeogenesis and glycolysis.

Adv Second Messenger Phosphoprotein Res ; 22 : — CAS PubMed Google Scholar. Pilkis SJ, el-Maghrabi MR, Claus TH. Hormonal regulation of hepatic gluconeogenesis and glycolysis. Annu Rev Biochem ; 57 : — Brouwers MC, Jacobs C, Bast A, Stehouwer CD, Schaper NC. Modulation of glucokinase regulatory protein: a double-edged sword?

Trends Mol Med ; 21 : — Dentin R, Girard J, Postic C. Carbohydrate responsive element binding protein ChREBP and sterol regulatory element binding protein-1c SREBP-1c : two key regulators of glucose metabolism and lipid synthesis in liver.

Biochimie ; 87 : 81— Horton JD, Goldstein JL, Brown MS. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver.

J Clin Invest ; : — Article CAS PubMed PubMed Central Google Scholar. Shimano H, Yahagi N, Amemiya-Kudo M, Hasty AH, Osuga J, Tamura Y et al.

Sterol regulatory element-binding protein-1 as a key transcription factor for nutritional induction of lipogenic enzyme genes.

J Biol Chem ; : — Im SS, Yousef L, Blaschitz C, Liu JZ, Edwards RA, Young SG et al. Linking lipid metabolism to the innate immune response in macrophages through sterol regulatory element binding protein-1a. Cell Metab ; 13 : — Jeon TI, Osborne TF. SREBPs: metabolic integrators in physiology and metabolism.

Trends Endocrinol Metab ; 23 : 65— Repa JJ, Liang G, Ou J, Bashmakov Y, Lobaccaro JM, Shimomura I et al.

Regulation of mouse sterol regulatory element-binding protein-1c gene SREBP-1c by oxysterol receptors, LXRalpha and LXRbeta.

Genes Dev ; 14 : — Lu M, Shyy JY. Sterol regulatory element-binding protein 1 is negatively modulated by PKA phosphorylation. Am J Physiol Cell Physiol ; : C—C Bengoechea-Alonso MT, Ericsson J.

A phosphorylation cascade controls the degradation of active SREBP1. Yoon YS, Seo WY, Lee MW, Kim ST, Koo SH. Salt-inducible kinase regulates hepatic lipogenesis by controlling SREBP-1c phosphorylation.

Li Y, Xu S, Mihaylova MM, Zheng B, Hou X, Jiang B et al. AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice. Yamashita H, Takenoshita M, Sakurai M, Bruick RK, Henzel WJ, Shillinglaw W et al. A glucose-responsive transcription factor that regulates carbohydrate metabolism in the liver.

Proc Natl Acad Sci USA ; 98 : — Ma L, Tsatsos NG, Towle HC. Direct role of ChREBP. Mlx in regulating hepatic glucose-responsive genes.

Mitro N, Mak PA, Vargas L, Godio C, Hampton E, Molteni V et al. The nuclear receptor LXR is a glucose sensor. Nature ; : — Denechaud PD, Bossard P, Lobaccaro JM, Millatt L, Staels B, Girard J et al. ChREBP, but not LXRs, is required for the induction of glucose-regulated genes in mouse liver.

CAS PubMed PubMed Central Google Scholar. Kawaguchi T, Osatomi K, Yamashita H, Kabashima T, Uyeda K. Mechanism for fatty acid "sparing" effect on glucose-induced transcription: regulation of carbohydrate-responsive element-binding protein by AMP-activated protein kinase.

Kawaguchi T, Takenoshita M, Kabashima T, Uyeda K. Tsatsos NG, Davies MN, O'Callaghan BL, Towle HC. Identification and function of phosphorylation in the glucose-regulated transcription factor ChREBP.

Biochem J ; : — Tsatsos NG, Towle HC. Glucose activation of ChREBP in hepatocytes occurs via a two-step mechanism. Biochem Biophys Res Commun ; : — Iizuka K, Horikawa Y. ChREBP: a glucose-activated transcription factor involved in the development of metabolic syndrome. Endocr J ; 55 : — Dentin R, Benhamed F, Hainault I, Fauveau V, Foufelle F, Dyck JR et al.

Diabetes ; 55 : — Oh KJ, Han HS, Kim MJ, Koo SH. CREB and FoxO1: two transcription factors for the regulation of hepatic gluconeogenesis. BMB Rep ; 46 : — Arias J, Alberts AS, Brindle P, Claret FX, Smeal T, Karin M et al. Activation of cAMP and mitogen responsive genes relies on a common nuclear factor.

Chrivia JC, Kwok RP, Lamb N, Hagiwara M, Montminy MR, Goodman RH. Phosphorylated CREB binds specifically to the nuclear protein CBP.

Altarejos JY, Montminy M. CREB and the CRTC co-activators: sensors for hormonal and metabolic signals. Nat Rev Mol Cell Biol ; 12 : — Conkright MD, Canettieri G, Screaton R, Guzman E, Miraglia L, Hogenesch JB et al. TORCs: transducers of regulated CREB activity.

Mol Cell ; 12 2 : — Koo SH, Flechner L, Qi L, Zhang X, Screaton RA, Jeffries S et al. The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism.

Erion DM, Ignatova ID, Yonemitsu S, Nagai Y, Chatterjee P, Weismann D et al. Prevention of hepatic steatosis and hepatic insulin resistance by knockdown of cAMP response element-binding protein.

Cell Metab ; 10 : — Herzig S, Long F, Jhala US, Hedrick S, Quinn R, Bauer A et al. CREB regulates hepatic gluconeogenesis through the coactivator PGC Bedford DC, Kasper LH, Wang R, Chang Y, Green DR, Brindle PK.

Disrupting the CH1 domain structure in the acetyltransferases CBP and p results in lean mice with increased metabolic control. Cell Metab ; 14 : — Screaton RA, Conkright MD, Katoh Y, Best JL, Canettieri G, Jeffries S et al. The CREB coactivator TORC2 functions as a calcium- and cAMP-sensitive coincidence detector.

Cell ; : 61— Wang Y, Li G, Goode J, Paz JC, Ouyang K, Screaton R et al. Inositol-1,4,5-trisphosphate receptor regulates hepatic gluconeogenesis in fasting and diabetes. Yoon YS, Lee MW, Ryu D, Kim JH, Ma H, Seo WY et al.

Proc Natl Acad Sci USA a ; : — Dentin R, Hedrick S, Xie J, Yates J 3rd, Montminy M. Hepatic glucose sensing via the CREB coactivator CRTC2. Science ; : — Han HS, Jung CY, Yoon YS, Choi S, Choi D, Kang G et al. Arginine methylation of CRTC2 is critical in the transcriptional control of hepatic glucose metabolism.

Sci Signal ; 7 : ra Article PubMed Google Scholar. Wang Y, Inoue H, Ravnskjaer K, Viste K, Miller N, Liu Y et al. Targeted disruption of the CREB coactivator Crtc2 increases insulin sensitivity.

Proc Natl Acad Sci USA ; : — Lee MW, Chanda D, Yang J, Oh H, Kim SS, Yoon YS et al. Regulation of hepatic gluconeogenesis by an ER-bound transcription factor, CREBH. Cell Metab ; 11 : — Wang Y, Vera L, Fischer WH, Montminy M. The CREB coactivator CRTC2 links hepatic ER stress and fasting gluconeogenesis.

Accili D, Arden KC. FoxOs at the crossroads of cellular metabolism, differentiation, and transformation. Cell ; : — Barthel A, Schmoll D, Unterman TG. FoxO proteins in insulin action and metabolism. Trends Endocrinol Metab ; 16 : — Biggs WH 3rd, Meisenhelder J, Hunter T, Cavenee WK, Arden KC.

Proc Natl Acad Sci USA ; 96 : — Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS et al. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell ; 96 : — Nakae J, Park BC, Accili D.

Insulin stimulates phosphorylation of the forkhead transcription factor FKHR on serine through a Wortmannin-sensitive pathway. Daitoku H, Hatta M, Matsuzaki H, Aratani S, Ohshima T, Miyagishi M et al. Silent information regulator 2 potentiates Foxo1-mediated transcription through its deacetylase activity.

Haeusler RA, Kaestner KH, Accili D. FoxOs function synergistically to promote glucose production. Matsumoto M, Pocai A, Rossetti L, Depinho RA, Accili D. Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor Foxo1 in liver.

Cell Metab ; 6 : — Puigserver P, Rhee J, Donovan J, Walkey CJ, Yoon JC, Oriente F et al. Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction. Puigserver P, Wu Z, Park CW, Graves R, Wright M, Spiegelman BM. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis.

Cell ; 92 : — Yoon JC, Puigserver P, Chen G, Donovan J, Wu Z, Rhee J et al. Control of hepatic gluconeogenesis through the transcriptional coactivator PGC Koo SH, Satoh H, Herzig S, Lee CH, Hedrick S, Kulkarni R et al.

PGC-1 promotes insulin resistance in liver through PPAR-alpha-dependent induction of TRB Nat Med ; 10 : — Lin J, Wu PH, Tarr PT, Lindenberg KS, St-Pierre J, Zhang CY et al. Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1alpha null mice.

Yamagata K, Daitoku H, Takahashi Y, Namiki K, Hisatake K, Kako K et al. Arginine methylation of FOXO transcription factors inhibits their phosphorylation by Akt. Mol Cell ; 32 : — Choi D, Oh KJ, Han HS, Yoon YS, Jung CY, Kim ST et al.

Protein arginine methyltransferase 1 regulates hepatic glucose production in a FoxO1-dependent manner. Hepatology ; 56 : — Evans RM, Mangelsdorf DJ. Nuclear Receptors, RXR, and the Big Bang. van Schaftingen E, Gerin I. The glucosephosphatase system. Zinker B, Mika A, Nguyen P, Wilcox D, Ohman L, von Geldern TW et al.

Liver-selective glucocorticoid receptor antagonism decreases glucose production and increases glucose disposal, ameliorating insulin resistance. Metabolism ; 56 : — Kim DK, Gang GT, Ryu D, Koh M, Kim YN, Kim SS et al. Inverse agonist of nuclear receptor ERRgamma mediates antidiabetic effect through inhibition of hepatic gluconeogenesis.

Diabetes ; 62 : — Kim DK, Ryu D, Koh M, Lee MW, Lim D, Kim MJ et al. Orphan nuclear receptor estrogen-related receptor gamma ERRgamma is key regulator of hepatic gluconeogenesis. Iyer AK, McCabe ER. Molecular mechanisms of DAX1 action.

Mol Genet Metab ; 83 : 60— Seol W, Choi HS, Moore DD. An orphan nuclear hormone receptor that lacks a DNA binding domain and heterodimerizes with other receptors.

Xie YB, Lee OH, Nedumaran B, Seong HA, Lee KM, Ha H et al. SMILE, a new orphan nuclear receptor SHP-interacting protein, regulates SHP-repressed estrogen receptor transactivation.

Kim YD, Park KG, Lee YS, Park YY, Kim DK, Nedumaran B et al.

Gao Z, Zhang X, Zuberi A, et al. Inhibition of insulin sensitivity by free fatty acids requires activation of multiple serine kinases in 3T3-L1 adipocytes. Mol Endocrinol. Yu C, Chen Y, Cline GW, et al. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 IRS-1 -associated phosphatidylinositol 3-kinase activity in muscle.

Shoelson SE, Lee J, Yuan M. Int J Obes Relat Metab Disord. Cai D, Yuan M, Frantz DF, et al. Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Tremblay F, Brule S, Hee Um S, et al. Identification of IRS-1 Ser as a target of S6K1 in nutrient- and obesity-induced insulin resistance.

Krebs M, Brunmair B, Brehm A, et al. The Mammalian target of rapamycin pathway regulates nutrient-sensitive glucose uptake in man. Fraenkel M, Ketzinel-Gilad M, Ariav Y, et al.

mTOR inhibition by rapamycin prevents beta-cell adaptation to hyperglycemia and exacerbates the metabolic state in type 2 diabetes.

Yamauchi T, Kamon J, Ito Y, et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Maeda N, Shimomura I, Kishida K, et al. Bugianesi E, Pagotto U, Manini R, et al.

Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity. Hui JM, Hodge A, Farrell GC, Kench JG, Kriketos A, George J.

Beyond insulin resistance in NASH: TNF-alpha or adiponectin? Xu A, Wang Y, Keshaw H, Xu LY, Lam KS, Cooper GJ.

The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. Kaser S, Moschen A, Cayon A, et al. Adiponectin and its receptors in non-alcoholic steatohepatitis. Kaser S, Foger B, Waldenberger P, et al. Transjugular intrahepatic portosystemic shunt TIPS augments hyperinsulinemia in patients with cirrhosis.

J Hepatol. Harle P, Straub RH. Leptin is a link between adipose tissue and inflammation. Petersen KF, Oral EA, Dufour S, et al. Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy.

Aleffi S, Petrai I, Bertolani C, et al. Upregulation of proinflammatory and proangiogenic cytokines by leptin in human hepatic stellate cells. Leclercq IA, Farrell GC, Schriemer R, Robertson GR. Leptin is essential for the hepatic fibrogenic response to chronic liver injury.

McCullough AJ, Bugianesi E, Marchesini G, Kalhan SC. Gender-dependent alterations in serum leptin in alcoholic cirrhosis. Nolte W, Wirtz M, Rossbach C, et al. TIPS implantation raises leptin levels in patients with liver cirrhosis. Exp Clin Endocrinol Diabetes.

Liangpunsakul S, Chalasani N. Relationship between unexplained elevations in alanine aminotransferase and serum leptin in U. adults: results from the Third National Health and Nutrition Examination Survey NHANES III.

J Clin Gastroenterol. Bethanis SK, Theocharis SE. Leptin in the field of hepatic fibrosis: a pivotal or an incidental player? Dig Dis Sci. Steppan CM, Bailey ST, Bhat S, et al. The hormone resistin links obesity to diabetes.

Rajala MW, Qi Y, Patel HR, et al. Regulation of resistin expression and circulating levels in obesity, diabetes, and fasting. Rangwala SM, Rich AS, Rhoades B, et al.

Abnormal glucose homeostasis due to chronic hyperresistinemia. Rajala MW, Obici S, Scherer PE, Rossetti L. Adipose-derived resistin and gut-derived resistin-like molecule-beta selectively impair insulin action on glucose production.

Muse ED, Obici S, Bhanot S, et al. Role of resistin in diet-induced hepatic insulin resistance. Way JM, Gorgun CZ, Tong Q, et al.

Adipose tissue resistin expression is severely suppressed in obesity and stimulated by peroxisome proliferator-activated receptor gamma agonists. Engeli S, Bohnke J, Feldpausch M, et al. Regulation of 11beta-HSD genes in human adipose tissue: influence of central obesity and weight loss.

Obes Res. Patel K, Muir A, McHutchison JG, Patton HM. A link between leptin and steatosis in chronic hepatitis C? Time to weigh up the fats. Am J Gastroenterol.

Savage DB, Sewter CP, Klenk ES, et al. McTernan CL, McTernan PG, Harte AL, Levick PL, Barnett AH, Kumar S. Resistin, central obesity, and type 2 diabetes. McTernan PG, McTernan CL, Chetty R, et al. Increased resistin gene and protein expression in human abdominal adipose tissue.

Lin SY, Sheu WH, Chen WY, Lee FY, Huang CJ. Stimulated resistin expression in white adipose of rats with bile duct ligation-induced liver cirrhosis: relationship to cirrhotic hyperinsulinemia and increased tumor necrosis factor-alpha.

Mol Cell Endocrinol. Yagmur E, Trautwein C, Gressner AM, Tacke F. Resistin serum levels are associated with insulin resistance, disease severity, clinical complications, and prognosis in patients with chronic liver diseases.

Bahr MJ, Ockenga J, Boker KH, Manns MP, Tietge UJ. Elevated resistin levels in cirrhosis are associated with the proinflammatory state and altered hepatic glucose metabolism but not with insulin resistance. Pagano C, Soardo G, Pilon C, et al.

Increased serum resistin in nonalcoholic fatty liver disease is related to liver disease severity and not to insulin resistance. Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM.

IRSmediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS.

Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Li Z, Yang S, Lin H, et al. Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease.

Fried SK, Bunkin DA, Greenberg AS. Omental and subcutaneous adipose tissues of obese subjects release interleukin depot difference and regulation by glucocorticoid. Fernandez-Real JM, Vayreda M, Richart C, et al. Circulating interleukin 6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women.

Andreozzi F, Laratta E, Cardellini M, et al. Plasma interleukin-6 levels are independently associated with insulin secretion in a cohort of Italian-Caucasian nondiabetic subjects. Weigert C, Hennige AM, Brodbeck K, Haring HU, Schleicher ED.

Interleukin-6 acts as insulin sensitizer on glycogen synthesis in human skeletal muscle cells by phosphorylation of Ser of Akt. Weigert C, Hennige AM, Lehmann R, et al. Direct cross-talk of interleukin-6 and insulin signal transduction via insulin receptor substrate-1 in skeletal muscle cells.

Hoene M, Weigert C. The role of interleukin-6 in insulin resistance, body fat distribution and energy balance. Obes Rev. Di Gregorio GB, Hensley L, Lu T, Ranganathan G, Kern PA.

Lipid and carbohydrate metabolism in mice with a targeted mutation in the IL-6 gene: absence of development of age-related obesity.

Wallenius V, Wallenius K, Ahren B, et al. Interleukindeficient mice develop mature-onset obesity. Marchesini G, Brizi M, Morselli-Labate AM, et al.

Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med. Marchesini G, Brizi M, Bianchi G, et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Bugianesi E, McCullough AJ, Marchesini G. Insulin resistance: a metabolic pathway to chronic liver disease.

Kim SP, Ellmerer M, Van Citters GW, Bergman RN. Primacy of hepatic insulin resistance in the development of the metabolic syndrome induced by an isocaloric moderate-fat diet in the dog. Kraegen EW, Clark PW, Jenkins AB, Daley EA, Chisholm DJ, Storlien LH.

Development of muscle insulin resistance after liver insulin resistance in high-fat-fed rats. Kim JK, Fillmore JJ, Chen Y, et al. Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance.

Friedman J. Fat in all the wrong places. Caldwell SH, Swerdlow RH, Khan EM, et al. Mitochondrial abnormalities in non-alcoholic steatohepatitis. Matsumoto M, Han S, Kitamura T, Accili D.

Dual role of transcription factor FoxO1 in controlling hepatic insulin sensitivity and lipid metabolism. Allison ME, Wreghitt T, Palmer CR, Alexander GJ. Evidence for a link between hepatitis C virus infection and diabetes mellitus in a cirrhotic population.

Mehta SH, Brancati FL, Sulkowski MS, Strathdee SA, Szklo M, Thomas DL. Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Ann Intern Med. Mangia A, Schiavone G, Lezzi G, et al.

HCV and diabetes mellitus: evidence for a negative association. Shaheen M, Echeverry D, Oblad MG, Montoya MI, Teklehaimanot S, Akhtar AJ. Hepatitis C, metabolic syndrome, and inflammatory markers: results from the Third National Health and Nutrition Examination Survey [NHANES III].

Diabetes Res Clin Pract. Hui JM, Sud A, Farrell GC, et al. Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression [corrected]. Tazawa J, Maeda M, Nakagawa M, et al.

Diabetes mellitus may be associated with hepatocarcinogenesis in patients with chronic hepatitis C. Shintani Y, Fujie H, Miyoshi H, et al. Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance.

Tsutsumi T, Suzuki T, Moriya K, et al. Alteration of intrahepatic cytokine expression and AP-1 activation in transgenic mice expressing hepatitis C virus core protein. Aytug S, Reich D, Sapiro LE, Bernstein D, Begum N. Kawaguchi T, Yoshida T, Harada M, et al.

Hepatitis C virus down-regulates insulin receptor substrates 1 and 2 through up-regulation of suppressor of cytokine signaling 3. Am J Pathol. Nothnagel E. Handbuch Spezielle Pathologie Therapie 7. Glycosurie und Diabetes durch experimentelle Insulte und Krankheiten der Leber. In: E. N, editor.

Handbuch Spez. Vol B and 7. Wien: A. Holder; pp. Google Scholar. Buzzelli G, Chiarantini E, Cotrozzi G, et al. Estimate of prevalence of glucose intolerance in chronic liver disease.

Degree of agreement among some diagnostic criteria. Creutzfeldt W, Frerichs H, Sickinger K. Liver diseases and diabetes mellitus.

Prog Liver Dis. Gentile S, Turco S, Guarino G, et al. Effect of treatment with acarbose and insulin in patients with non-insulin-dependent diabetes mellitus associated with non-alcoholic liver cirrhosis.

Diabetes Obes Metab. Holstein A, Hinze S, Thiessen E, Plaschke A, Egberts EH. Clinical implications of hepatogenous diabetes in liver cirrhosis. J Gastroen terol Hepatol.

Bianchi G, Marchesini G, Zoli M, Bugianesi E, Fabbri A, Pisi E. Prognostic significance of diabetes in patients with cirrhosis. Vannini P, Forlani G, Marchesini G, Ciavarella A, Zoli M, Pisi E. The euglycemic clamp technique in patients with liver cirrhosis.

Horm Metab Res. Muller MJ, Willmann O, Rieger A, et al. Mechanism of insulin resistance associated with liver cirrhosis. Kruszynska Y, Williams N, Perry M, Home P.

The relationship between insulin sensitivity and skeletal muscle enzyme activities in hepatic cirrhosis. Taylor R, Heine RJ, Collins J, James OF, Alberti KG.

Insulin action in cirrhosis. Nolte W, Hartmann H, Ramadori G. Glucose metabolism and liver cirrhosis. Raddatz D, Nolte W, Rossbach C, et al. Measuring the effect of a study meal on portal concentrations of glucagon-like peptide 1 GLP-1 in non diabetic and diabetic patients with liver cirrhosis: transjugular intrahepatic portosystemic stent shunt TIPSS as a new method for metabolic measurements.

Rittig K, Peter A, Baltz KM, et al. The CCR2 promoter polymorphism TA, but not the serum MCP-1 level, is associated with endothelial function in prediabetic individuals.

Kruszynska YT, Home PD, McIntyre N. Relationship between insulin sensitivity, insulin secretion and glucose tolerance in cirrhosis. Raddatz D, Rossbach C, Buchwald A, Scholz KH, Ramadori G, Nolte W.

Fasting hyperglucagonemia in patients with transjugular intrahepatic portosystemic shunts TIPS. Perseghin G, Mazzaferro V, Sereni LP, et al.

Contribution of reduced insulin sensitivity and secretion to the pathogenesis of hepatogenous diabetes: effect of liver transplantation. Download references. Department of Gastroenterology and Endocrinology, University of Göttingen, Göttingen, Germany. You can also search for this author in PubMed Google Scholar.

Correspondence to Dirk Raddatz. School of Medicine, Dept. Pathology, University of Pittsburgh, Lothrop Street, SBST, Pittsburgh, , Pennsylvania, USA. Reprints and permissions. Raddatz, D. Hepatic Carbohydrate Metabolism. In: Monga, S. eds Molecular Pathology of Liver Diseases. Molecular Pathology Library, vol 5.

Springer, Boston, MA. Published : 02 November Publisher Name : Springer, Boston, MA. Print ISBN : Online ISBN : eBook Packages : Medicine Medicine R0.

Anyone you share the following link with will be able to read this content:. Sorry, a shareable link is not currently available for this article. Provided by the Springer Nature SharedIt content-sharing initiative.

Policies and ethics. Skip to main content. Abstract The liver plays a unique role in controlling carbohydrate metabolism by maintaining glucose concentrations in a normal range. Keywords Insulin Resistance Insulin Receptor Substrate Hepatic Glucose Production Growth Hormone Action Acid Labile Subunit These keywords were added by machine and not by the authors.

Buying options Chapter EUR eBook EUR Softcover Book EUR Hardcover Book EUR Tax calculation will be finalised at checkout Purchases are for personal use only Learn about institutional subscriptions. References Pagliassotti MJ, Cherrington AD. PubMed CAS Google Scholar Radziuk J.

PubMed CAS Google Scholar Pencek RR, James F, Lacy DB, et al. PubMed CAS Google Scholar Roden M, Petersen KF, Shulman GI. PubMed CAS Google Scholar Gardemann A, Strulik H, Jungermann K. PubMed CAS Google Scholar Stumpel F, Scholtka B, Jungermann K.

PubMed CAS Google Scholar Toffolo G, Campioni M, Basu R, Rizza RA, Cobelli C. PubMed CAS Google Scholar Valera A, Bosch F.

PubMed CAS Google Scholar Girard J, Ferre P, Foufelle F. PubMed CAS Google Scholar Ferre T, Riu E, Bosch F, Valera A. PubMed CAS Google Scholar Ferre T, Pujol A, Riu E, Bosch F, Valera A.

PubMed CAS Google Scholar Johnson D, Shepherd RM, Gill D, Gorman T, Smith DM, Dunne MJ. PubMed CAS Google Scholar Postic C, Dentin R, Girard J. PubMed CAS Google Scholar Dentin R, Benhamed F, Hainault I, et al. PubMed CAS Google Scholar Dentin R, Pegorier JP, Benhamed F, et al.

PubMed CAS Google Scholar Giacca A, Fisher SJ, Shi ZQ, Gupta R, Lickley HL, Vranic M. PubMed CAS Google Scholar Lewis GF, Zinman B, Groenewoud Y, Vranic M, Giacca A.

PubMed CAS Google Scholar Ferrannini E, Galvan AQ, Gastaldelli A, et al. PubMed CAS Google Scholar Duong DT, Waltner-Law ME, Sears R, Sealy L, Granner DK. PubMed Google Scholar Lewis GF, Vranic M, Giacca A.

PubMed CAS Google Scholar Obici S, Zhang BB, Karkanias G, Rossetti L. PubMed CAS Google Scholar Cherrington AD, Edgerton D, Sindelar DK. PubMed CAS Google Scholar Sindelar DK, Chu CA, Venson P, Donahue EP, Neal DW, Cherrington AD. PubMed CAS Google Scholar Edgerton DS, Lautz M, Scott M, et al.

PubMed CAS Google Scholar Fisher SJ, Kahn CR. PubMed CAS Google Scholar Okamoto H, Obici S, Accili D, Rossetti L. PubMed CAS Google Scholar Michael MD, Kulkarni RN, Postic C, et al. PubMed CAS Google Scholar Buettner C, Patel R, Muse ED, et al. PubMed CAS Google Scholar Cherrington AD. PubMed CAS Google Scholar Girard J.

PubMed CAS Google Scholar Jungermann K, Gardemann A, Beuers U, et al. PubMed CAS Google Scholar Pocai A, Obici S, Schwartz GJ, Rossetti L. PubMed CAS Google Scholar Magnusson I, Rothman DL, Katz LD, Shulman RG, Shulman GI.

PubMed CAS Google Scholar Reaven GM, Chen YD, Golay A, Swislocki AL, Jaspan JB. PubMed CAS Google Scholar Pilkis SJ, Granner DK. PubMed CAS Google Scholar Christ B, Nath A, Bastian H, Jungermann K. PubMed CAS Google Scholar Yoon JC, Puigserver P, Chen G, et al.

PubMed CAS Google Scholar Puigserver P, Rhee J, Donovan J, et al. PubMed CAS Google Scholar Christ B, Yazici E, Nath A. PubMed CAS Google Scholar Metzger S, Goldschmidt N, Barash V, et al.

PubMed CAS Google Scholar Inoue H, Ogawa W, Ozaki M, et al. PubMed CAS Google Scholar Sun Y, Liu S, Ferguson S, et al. PubMed CAS Google Scholar Barzilai N, Rossetti L. PubMed CAS Google Scholar Burchell A, Cain DI.

PubMed CAS Google Scholar Valera A, Pujol A, Pelegrin M, Bosch F. PubMed CAS Google Scholar Samuel VT, Beddow SA, Iwasaki T, et al. PubMed CAS Google Scholar Yakar S, Liu JL, Fernandez AM, et al.

PubMed CAS Google Scholar Fernandez AM, Kim JK, Yakar S, et al. PubMed CAS Google Scholar Haluzik M, Yakar S, Gavrilova O, Setser J, Boisclair Y, LeRoith D. PubMed CAS Google Scholar Yakar S, Setser J, Zhao H, et al. PubMed Google Scholar Desbriere R, Vuaroqueaux V, Achard V, et al.

CAS Google Scholar Masuzaki H, Paterson J, Shinyama H, et al. PubMed CAS Google Scholar Kotelevtsev Y, Holmes MC, Burchell A, et al. PubMed CAS Google Scholar Morton NM, Holmes MC, Fievet C, et al.

PubMed CAS Google Scholar Masuzaki H, Yamamoto H, Kenyon CJ, et al. PubMed CAS Google Scholar Basu R, Basu A, Grudzien M, et al. PubMed CAS Google Scholar Paulsen SK, Pedersen SB, Jorgensen JO, et al. PubMed CAS Google Scholar Thieringer R, Hermanowski-Vosatka A.

PubMed CAS Google Scholar Wang M. PubMed CAS Google Scholar White MF. PubMed CAS Google Scholar Saltiel AR, Pessin JE. PubMed CAS Google Scholar Sesti G, Federici M, Hribal ML, Lauro D, Sbraccia P, Lauro R.

PubMed Google Scholar Suzuki R, Tobe K, Aoyama M, et al. PubMed CAS Google Scholar Dong X, Park S, Lin X, Copps K, Yi X, White MF. PubMed CAS Google Scholar Simmgen M, Knauf C, Lopez M, et al.

Endocrine Society Journals. Advanced Search. Search Menu. Article Navigation. Close mobile search navigation Article Navigation. Volume Journal Article. SAMUEL SOSKIN SAMUEL SOSKIN.

Oxford Academic. Google Scholar. Select Format Select format. ris Mendeley, Papers, Zotero. enw EndNote. bibtex BibTex. txt Medlars, RefWorks Download citation.

Permissions Icon Permissions. Close Navbar Search Filter Endocrinology This issue Endocrine Society Journals Clinical Medicine Endocrinology and Diabetes Medicine and Health Books Journals Oxford Academic Enter search term Search. Abstract THE SECRETION of sugar into the blood by the liver of the fasting animal 11 was demonstrated by the brilliant pioneer work of Claude Bernard i.

Issue Section:. You do not currently have access to this article. Download all slides. Sign in Get help with access. Endocrine Society members Sign in through society site.

Get help with access Institutional access Access to content on Oxford Academic is often provided through institutional subscriptions and purchases. If you are a member of an institution with an active account, you may be able to access content in one of the following ways: IP based access Typically, access is provided across an institutional network to a range of IP addresses.

Sign in through your institution Choose this option to get remote access when outside your institution. Click Sign in through your institution. Select your institution from the list provided, which will take you to your institution's website to sign in. When on the institution site, please use the credentials provided by your institution.

Do not use an Oxford Academic personal account. Following successful sign in, you will be returned to Oxford Academic. Sign in with a library card Enter your library card number to sign in.

Society Members Society member access to a journal is achieved in one of the following ways: Sign in through society site Many societies offer single sign-on between the society website and Oxford Academic.

When on the society site, please use the credentials provided by that society. Sign in using a personal account Some societies use Oxford Academic personal accounts to provide access to their members. Personal account A personal account can be used to get email alerts, save searches, purchase content, and activate subscriptions.

Viewing your signed in accounts Click the account icon in the top right to: View your signed in personal account and access account management features. View the institutional accounts that are providing access. Signed in but can't access content Oxford Academic is home to a wide variety of products.

Institutional account management For librarians and administrators, your personal account also provides access to institutional account management. Purchase Subscription prices and ordering for this journal. Purchasing options for books and journals across Oxford Academic.

Short-term Access To purchase short-term access, please sign in to your personal account above. This article is also available for rental through DeepDyve.

Views More metrics information. Total Views Month: Total Views: February 11 May 1 June 1 August 1 November 1 May 1 March 1 January 1 March 1 April 1 May 1 July 1 October 3.

Email alerts Article activity alert. Advance article alerts. New issue alert. Receive exclusive offers and updates from Oxford Academic.